Genetic polymorphism of a MAO in mental disorders;Polimorfizm genu MAO w zaburzeniach psychicznych

Psychiatria Polska

Volumn 41, Issue 4, 2007, Pages 485-493

  Tylec, Aneta ^a,b   Stryjecka Zimmer, Marta ^b   Kucharska Pietura, Katarzyna ^c  

^a Katedra I Klinika Psychiatrii AM W Lublinie

^b Katedra I Zakład Biochemii I Biologii Molekularnej AM W Lublinie ^*  (Poland)

^c WHITCHURCH HOSPITAL   (United Kingdom)

Author keywords

MAO; Mental disorders; Polymorphism

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B;

ALCOHOLISM; BEHAVIOR DISORDER; CATALYSIS; CHEMICAL REACTION; CHROMOSOME XP; ENZYME ACTIVITY; GENE; GENE SEQUENCE; GENETIC POLYMORPHISM; MAO GENE; MENTAL DISEASE; MOOD DISORDER; PATHOGENESIS; PERSONALITY DISORDER; REVIEW; SCHIZOPHRENIA; GENETIC PREDISPOSITION; GENETICS; HUMAN; RISK ASSESSMENT; RISK FACTOR;

ALCOHOLISM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENTAL DISORDERS; MONOAMINE OXIDASE; MOOD DISORDERS; PERSONALITY DISORDERS; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SCHIZOPHRENIA;

EID: 38549151865     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Blaschko H. The natural history of amine oxidase. Physiol. Biochem. Pharmacol. 1974; 70: 83-148.
2. Rybakowski J, Rzewuska M, Członkowski A. Moklobemid - atypowy inhibitor monoaminooksydazy (RIMA). Bielsko-Biała: α-medica press; 2000.
3. Cooper J, Bloom F, Roth R. Biochemical basis of neuropharmacology. London: Oxford University Press; 1970.
4. Gaal J, Hermecz I. Medicinal chemistry of present and future MAO-B inhibitors. W: Szeleny i I, red. Inhibitors of monoamine oxidase B. New York: Springer - Verlag; 1993, s. 76-78.
5. Glover V. Reversible inhibitors of monoamine oxidase A (RIMAS). W: Skolnick P, red. Antidepressants: new pharmacological stages. Humana Press Inc. 1997, s. 69-79.
6. Krishnan K. Monoamine oxidase inhibitors. W: Schatzberg A, Nemeroff Ch, red. Textbook of psychopharmacology. Washington: American Psychiatric Press; 1998, s. 19-24.
7. Grimsby J, Chen K, Wang L, Lan N, Shih J. Human monoamine oxydase A and B genes exhibit identical exon-intron organization. Proc. Nat. Acad. Sc. USA 1991; 88: 3637-3641.
8. Norton N, Kirov G, Zammit S, Jones G i in. Schizophrenia and functional polymorphism in the MAOA and COMT genes: no evidence for association or epistasis. Am. J. Med. Gen. 2002; 114: 491-496.
9. Kerage F, Bovier J, Tissot R. The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatr. Scand. 1987; 76: 303-308.
10. Strous RD, Bark N, Parsia S, Volavka J, Lachman H. Analysis of a functional the catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res. 1997; 69: 71-77.
11. Volavka J. Neurobiology of violence. Washington, DC: American Psychiatric Press; 1995.
12. Matsumoto Ch, Shinkai T, Hori H, Ohmori O, Nakamura J. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia. Psychiatry Res. 2004; 127: 1-7.
13. Chen Z, Hotamisligil GS, Huang JK, Wen L i in. Structure of the human gene for monoamine oxydase type A. Nucl. Acid. Res. 1991; 19: 4537-4541.
14. Dmitrzak-Wȩglarz M, Czerski P, Leszczyńska-Rodziewicz A. Przegla̧d badań genów kandyduja̧cych w schizofrenii. Wiad. Psychiatr. 2002; 5 (4): 265-271.
15. Lenders J, Eisenhofer G i in. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxydase are characterized by distinct neurochemical and clinical phenotypes. J. Clin. Invest. 1996; 97: 1010-1019.
16. DeLisi L, Devoto N, Lofthouse R, Poulter N, Smith A, Shelids G i in. Search for linkage to schizophrenia on the X and Y chromosomes. Am. J. Med. Genet. 1994; 54: 113-121.
17. Grimbsy J, Chen K, Devor E, Cloninger C, Shih J. Dinucleotide repeat (TG)n polymorphism in the MAO-B gene. Nucl. Acid. Res. 1992; 20: 924.
18. Wei J, Hemmings G. Lack of evidence for association between the COMT locus and schizophrenia. Psychiatr. Gen. 1999; 9, 4: 183-186.
19. Syagailo YV, Stober G, Grassle M, Reimer E, Knapp M, Jungkunz G, Okladnova O, Meyer J, Lesch KP. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. Am. J. Med. Genet. 2001; 8, 105 (2): 168-171.
20. Tybura P, Grzywacz A, Syrek S, Parus M, Samochowiec J. Zwia̧zki funkcjonalnych polimorfizmów genów kluczowych enzymów w metabolizmie amin biogennych z wystȩpowaniem schizofrenii paranoidalnej oraz ich wpływ na wyniki w PANSS pod wpływem leczenia przeciwpsychotycznego. Psychiatr. Pol. 2006; 40 (5): 913-923.
21. Turecki G, Grof P, Cavazzoni P, Duffy A i in. MAO-A: association and linkage studies with lithium responsive bipolar disorder. Psychiatr. Genet. 1999; 9: 13-16.
22. Ho D, Furlong R, Rubinsztain J, Walsh C i in. Genetic association with clinical characteristics in bipolar depressive disorder and recurrent unipolar depressive disorders. Am. J. Med. Genet. 2002; 96: 36-42.
23. Muramatsu T, Matsushita S, Kanba S, Higuchi S i in. Monoamino oxidase genes polymorphisms and mood disorder. Am. J. Med. Genet. 1997; 74: 494-496.
24. Craddock N, Daniels J, Roberts E, Rees M i in. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. Am. J. Med. Genet. 1995; 60 (4): 322-324.
25. Furlong R i in. Analysis of the monoamine oxidase A (MAO-A) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter. Am. J. Med. Genet. 1999; 88 (4): 398-406.
26. Preisig M, Bellivier F, Fenton B, Baud P i in. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: Results of a multicenter study. Am. J. Psychiatry 2000; 157 (6): 948-956.
27. Lin S, Jiang S, Wu X, Qian Y i in. Association analysis between mood disorders and monoamine oxidase gene. Am. J. Med. Genet. 2000; 96: 12-14.
28. Rubinsztein D, Leggo J, Goodburn S, Walsh C, Jain S, Paykel E. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Hum. Mol. Genet. 1996 5: 779-782.
29. Sabol S, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet 1998; 103: 273-279.
30. Deckert J, Catalano M, Syagailo Y, Bosi M.i in. Excess of high activity monoamine oxidase A gene promoter alleles in fernale patients with panic disorder. Hum. Molec. Genet. 1999; 8: 621-624.
31. Hauser J, Leszczyńska A, Samochowiec J, Ostapowicz A i in. The association study of the functional polymorphism of the MAO-A gene promoter in patients with affective disorders. Arch. Psychiatr. 2002.
32. Konardi C, Ozelius L, Breakfield X. Highly polymorphic (GT)n repeat sequence in intron II of the human MAO-B gene. Genom. 1992; 12: 176-177.
33. Lin S, Jiang S, Wu X, Qian Y i in. Association analysis between mood disorders and monoamine oxidase gene. Am. J. Med. Genet. 2000; 96: 12-14.
34. Craddock N, O'Donovan M, Owen M. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 2006; 1: 9-16.
35. Brunner H, Nelen M, Breakefeld X, Ropers H, van Oost B. Abnormal behaviour associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993; 262: 578-580.
36. Capsi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 2002; 297: 851-854.
37. Meyer-Lindenberg A, Buckholtz J, Kolachana B, Hariri A, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott J, Egan M, Mattay V, Weinberger D. Neural mechanisms of genetic risk for impulsivity and violence in humans. PNAS 2006; 103 (16): 6269-6274.
38. Hajduk A. A search for psychobiological determinants of anxiety disorders. Ann. Acad. Med. Stetin 2004; 50 (2): 65-75.
39. Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, Stepien G, Grzywacz A, Kucharska-Mazur J. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res. 2004; 128 (1): 21-26.
40. Arbelle S, Benjamin J, Golin M, Kremer I, Belmaker RH, Ebstein RP. Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. Am. J. Psychiatry 2003; 160 (4): 671-676.
41. Samochowiec J, Lesch K, Rottmann M, Okladnova O i in. Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatr. Res. 1999; 1: 67-72.
42. Schmidt L, Sander T, Kuhn S, Samochowiec J i in. Different allele distribution of a regulatory MAO-A promoter polymorphism in antisocial and anxious-deprresive alcoholics. J. Neural. Transm. 2000; 107: 681-689.
43. Pełka-Wysiecka J, Samochowiec J, Kucharska-Mazur J, Syrek Sz, Parus M i in. Zwia̧zek cech psychobiologicznych i polimorfizmów genów DRD3, DAT1, 5HTT, MAO A i COMT w populacji osób obcia̧żonych uzależnieniem od alkoholu. Post. Psychiatr. Neurol. 2004; 13, 4 (19): 35-46.
44. Samochowiec J. Molekularno-biologiczne mechanizmy zespołu zależności alkoholowej. Aachen: Shaker Verlag; 1999.
45. Parsian A, Cloninger CR, Sinha R, Zhang ZH. Functional variation in promoter region of monoamine oxidase A and subtypes of alcoholism: haplotype analysis. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2003; 117 (1): 46-50.
46. Garpenstrand H, Ekblom J, Forslund K, Rylander G, Oreland L. Platelet monoamine oxidase activity is related to MAO-B intron 13 genotype. J. Neural Transm. 2000; 107: 523-530.
47. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum. Genet. 2002; 110: 1-7.
48. Godlewski S, Czerski P. Badania genetyczno-molekularne metoda̧ analizy sprzȩżeń dotycza̧ce schizofrenii. Przegla̧d piśmiennictwa. Now. Lek. 2000; 69, 8: 705-718.
49. Glover V. Trials and tribulations with tribulin. Biogen. Am. 1993; 9: 443-452.